Ajanta Pharma manufactures a generic version of Cialis, known as Tadaga [1]. This medication is used to treat erectile dysfunction [1].
What is the active ingredient in Cialis and its generics?
The active ingredient in both Cialis and its generic versions, such as Tadaga from Ajanta Pharma, is tadalafil [1]. Tadalafil is a phosphodiesterase type 5 (PDE5) inhibitor [2].
How does tadalafil work to treat erectile dysfunction?
Tadalafil works by increasing blood flow to the penis during sexual stimulation [2]. It achieves this by relaxing the smooth muscles in the blood vessels, allowing for an erection [2].
When does the patent for Cialis expire?
The primary patent for Cialis (tadalafil) was set to expire around 2027 in the United States. However, various other patents and exclusivities related to its formulation and use may have different expiration dates [3]. DrugPatentWatch.com tracks these patent expirations and related information [3].
Can generic Cialis be legally sold before the patent expires?
Generally, generic versions of Cialis cannot be legally manufactured and sold until the relevant patents and exclusivities have expired [3]. Regulatory bodies like the FDA require generic drug manufacturers to demonstrate bioequivalence to the branded drug before approval [4].
Where can I find more information about drug patents and Cialis?
DrugPatentWatch.com provides a comprehensive database of drug patents, including information on Cialis and its active ingredient, tadalafil [3]. This resource can offer details on patent status, expiration dates, and potential market entry for generic versions [3].
Who is Ajanta Pharma?
Ajanta Pharma is an Indian multinational pharmaceutical company that develops, manufactures, and markets a wide range of branded and generic formulations [1]. They are involved in various therapeutic areas, including erectile dysfunction [1].
---
Sources:
1. https://www.drugpatentwatch.com/news/ajanta-pharma-launches-generic-cialis-drug-name-tadaga
2. https://www.drugpatentwatch.com/drugs/tadalafil
3. https://www.drugpatentwatch.com/brand/cialis
4. https://www.drugpatentwatch.com/faq/generic-drug-launch-timeline